Announcement PDF Appendix 3B - Proposed issue of securities Appendix 3B - Proposed issue of securities 1 / 5 Cancellation Summary Entity name ELIXINOL WELLNESS LIMITED Announcement Type Cancellation of previous announcement Date of this announcement 10/10/2025 Reason for cancellation of previous announcement This appendix was lodged with a cleansing prospectus and the offer period has now expired. Refer to next page for full details of the announcement Appendix 3B - Proposed issue of securities Appendix 3B - Proposed issue of securities 2 / 5 Part 1 - Entity and announcement details 1.1 Name of +Entity ELIXINOL WELLNESS LIMITED We (the entity named above) give ASX the following information about a proposed issue of +securities and, if ASX agrees to +quote any of the +securities (including any rights) on a +deferred settlement basis, we agree to the matters set out in Appendix 3B of the ASX Listing Rules. If the +securities are being offered under a +disclosure document or +PDS and are intended to be quoted on ASX, we also apply for quotation of all of the +securities that may be issued under the +disclosure document or +PDS on the terms set out in Appendix 2A of the ASX Listing Rules (on the understanding that once the final number of +securities issued under the +disclosure document or +PDS is known, in accordance with Listing Rule 3.10.3C, we will complete and lodge with ASX an Appendix 2A online form notifying ASX of their issue and applying for their quotation). 1.2 Registered Number Type ACN Registration Number 621479794 1.3 ASX issuer code EXL 1.4 The announcement is 1.4c Reason for cancellation of previous announcement This appendix was lodged with a cleansing prospectus and the offer period has now expired. 1.4d Date of previous announcement to this cancellation 15/9/2025 1.5 Date of this announcement 10/10/2025 1.6 The Proposed issue is: A non-+pro rata offer of +securities under a +disclosure document or +PDS Cancellation of previous announcement Appendix 3B - Proposed issue of securities Appendix 3B - Proposed issue of securities 3 / 5 Part 5 - Details of proposed non-pro rata offer under a +disclosure document or +PDS Part 5A - Conditions 5A.1 Do any external approvals need to be obtained or other conditions satisfied before the non-pro rata offer of +securities under a +disclosure document or + PDS can proceed on an unconditional basis? Part 5B - Offer details Is the proposed security a 'New class' (+securities in a class that is not yet quoted or recorded by ASX) or an 'Existing class' (additional securities in a class that is already quoted or recorded by ASX)? Will the proposed issue of this +security include an offer of attaching +securities? Details of +securities proposed to be issued ASX +security code and description EXL : ORDINARY FULLY PAID The number of +securities to be offered under the +disclosure document or +PDS 100,000 Will the offer be conditional on applications for a minimum number of +securities being received or a minimum amount being raised (i.e. a minimum subscription condition)? Will individual security holders be required to accept the offer for a minimum number or value of +securities (i.e. a minimum acceptance condition)? Will individual security holders be limited to accepting the offer for a maximum number or value of +securities (i.e. a maximum acceptance condition)? Offer price details Has the offer price been determined? In what currency will the offer be made? Yes No No No No Existing class No Appendix 3B - Proposed issue of securities Appendix 3B - Proposed issue of securities 4 / 5 made? AUD - Australian Dollar What is the offer price per +security? AUD 0.10000 Oversubscription & Scale back details Will the entity be entitled to accept over-subscriptions? Will a scale back be applied if the offer is over-subscribed? Will these +securities rank equally in all respects from their issue date with the existing issued +securities in that class? Part 5C - Timetable 5C.1 Lodgement date of +disclosure document or +PDS with ASIC 15/9/2025 5C.2 Date when +disclosure document or +PDS and acceptance forms will be made available to investors 16/9/2025 5C.3 Offer open date 16/9/2025 5C.4 Closing date for receipt of acceptances 1/10/2025 5C.6 Proposed +issue date 3/10/2025 Part 5D - Listing Rule requirements 5D.1 Has the entity obtained, or is it obtaining, +security holder approval for the entire issue under listing rule 7.1? 5D.1b Are any of the +securities proposed to be issued without +security holder approval using the entity's 15% placement capacity under listing rule 7.1? 5D.1b ( i ) How many +securities are proposed to be issued without +security holder approval using the entity's 15% placement capacity under listing rule 7.1? 100,000 full paid ordinary shares 5D.1c Are any of the +securities proposed to be issued without +security holder approval using the entity's additional 10% placement capacity under listing rule 7.1A (if applicable)? 5D.2 Is a party referred to in listing rule 10.11 participating in the proposed issue? No Yes No Yes No No Appendix 3B - Proposed issue of securities Appendix 3B - Proposed issue of securities 5 / 5 5D.2 Is a party referred to in listing rule 10.11 participating in the proposed issue? Part 5E - Fees and expenses 5E.1 Will there be a lead manager or broker to the proposed offer? 5E.2 Is the proposed offer to be underwritten? 5E.3 Will brokers who lodge acceptances or renunciations on behalf of eligible +security holders be paid a handling fee or commission? 5E.4 Details of any other material fees or costs to be incurred by the entity in connection with the proposed offer Part 5F - Further Information 5F.01 The purpose(s) for which the entity intends to use the cash raised by the proposed issue This is a cleansing prospectus, it is estimated that the expenses of this Offer will amount to approximately $10k, leaving a nil net effect of the offer upon the cash reserves if the Company proceeds with the allotment of the maximum number of new shares. 5F.1 Will the entity be changing its dividend/distribution policy if the proposed offer is successful? 5F.2 Please explain the entity's allocation policy for the offer, including whether or not acceptances from existing +security holders will be given priority Invited applicants 5F.3 URL on the entity's website where investors can download the +disclosure document or +PDS https://investorhub.elixinolwellness.com/announcements 5F.4 Any other information the entity wishes to provide about the proposed offer This is a cleansing prospectus only. No No No No No